Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nicholas P Restifo

Showing results (151-160 of 260) with videos related to

Pageof 26
Sort By:
The Journal of Clinical Investigation|November 8, 2011
IL-12 triggers a programmatic change in dysfunctional myeloid-derived cells within mouse tumorsSid P Kerkar, Romina S Goldszmid, Pawel Muranski, et al.
Journal of Immunology (Baltimore, Md. : 1950)|December 9, 2004
Vaccine-stimulated, adoptively transferred CD8+ T cells traffic indiscriminately and ubiquitously while mediating specific tumor destructionDouglas C Palmer, Sanjeeve Balasubramaniam, Ken-Ichi Hanada, et al.
The Journal of Clinical Investigation|July 28, 2007
Microbial translocation augments the function of adoptively transferred self/tumor-specific CD8+ T cells via TLR4 signalingChrystal M Paulos, Claudia Wrzesinski, Andrew Kaiser, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 19, 2007
Toll-like receptors in tumor immunotherapyChrystal M Paulos, Andrew Kaiser, Claudia Wrzesinski, et al.
Cancer Research Communications|June 28, 2023
Reprogramming of Tumor-reactive Tumor-infiltrating Lymphocytes to Human-induced Pluripotent Stem CellsS M Rafiqul Islam, Takuya Maeda, Naritaka Tamaoki, et al.
Journal of Immunology (Baltimore, Md. : 1950)|February 25, 2005
CD8+ T cell immunity against a tumor/self-antigen is augmented by CD4+ T helper cells and hindered by naturally occurring T regulatory cellsPaul A Antony, Ciriaco A Piccirillo, Akgül Akpinarli, et al.
Human Gene Therapy|April 4, 2014
A novel chimeric antigen receptor against prostate stem cell antigen mediates tumor destruction in a humanized mouse model of pancreatic cancerDaniel Abate-Daga, Kiran H Lagisetty, Eric Tran, et al.
The Journal of Experimental Medicine|October 6, 2005
Removal of homeostatic cytokine sinks by lymphodepletion enhances the efficacy of adoptively transferred tumor-specific CD8+ T cellsLuca Gattinoni, Steven E Finkelstein, Christopher A Klebanoff, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 12, 2013
T-cell receptor affinity and avidity defines antitumor response and autoimmunity in T-cell immunotherapyShi Zhong, Karolina Malecek, Laura A Johnson, et al.
Plos Biology|August 8, 2008
TSCOT+ thymic epithelial cell-mediated sensitive CD4 tolerance by direct presentationSejin Ahn, Gwanghee Lee, Soo Jung Yang, et al.
Pageof 26

Showing results (151-160 of 260) with videos related to

Sort By:
Pageof 26
The Journal of Clinical Investigation|November 8, 2011
IL-12 triggers a programmatic change in dysfunctional myeloid-derived cells within mouse tumorsSid P Kerkar, Romina S Goldszmid, Pawel Muranski, et al.
Journal of Immunology (Baltimore, Md. : 1950)|December 9, 2004
Vaccine-stimulated, adoptively transferred CD8+ T cells traffic indiscriminately and ubiquitously while mediating specific tumor destructionDouglas C Palmer, Sanjeeve Balasubramaniam, Ken-Ichi Hanada, et al.
The Journal of Clinical Investigation|July 28, 2007
Microbial translocation augments the function of adoptively transferred self/tumor-specific CD8+ T cells via TLR4 signalingChrystal M Paulos, Claudia Wrzesinski, Andrew Kaiser, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 19, 2007
Toll-like receptors in tumor immunotherapyChrystal M Paulos, Andrew Kaiser, Claudia Wrzesinski, et al.
Cancer Research Communications|June 28, 2023
Reprogramming of Tumor-reactive Tumor-infiltrating Lymphocytes to Human-induced Pluripotent Stem CellsS M Rafiqul Islam, Takuya Maeda, Naritaka Tamaoki, et al.
Journal of Immunology (Baltimore, Md. : 1950)|February 25, 2005
CD8+ T cell immunity against a tumor/self-antigen is augmented by CD4+ T helper cells and hindered by naturally occurring T regulatory cellsPaul A Antony, Ciriaco A Piccirillo, Akgül Akpinarli, et al.
Human Gene Therapy|April 4, 2014
A novel chimeric antigen receptor against prostate stem cell antigen mediates tumor destruction in a humanized mouse model of pancreatic cancerDaniel Abate-Daga, Kiran H Lagisetty, Eric Tran, et al.
The Journal of Experimental Medicine|October 6, 2005
Removal of homeostatic cytokine sinks by lymphodepletion enhances the efficacy of adoptively transferred tumor-specific CD8+ T cellsLuca Gattinoni, Steven E Finkelstein, Christopher A Klebanoff, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 12, 2013
T-cell receptor affinity and avidity defines antitumor response and autoimmunity in T-cell immunotherapyShi Zhong, Karolina Malecek, Laura A Johnson, et al.
Plos Biology|August 8, 2008
TSCOT+ thymic epithelial cell-mediated sensitive CD4 tolerance by direct presentationSejin Ahn, Gwanghee Lee, Soo Jung Yang, et al.
Pageof 26